161 related articles for article (PubMed ID: 25305042)
1. [Intravitreal fibrinolysis and retinal vein occlusion].
Bertelmann T; Stief T; Sekundo W; Witteborn M; Strodthoff S; Mennel S; Nguyen N; Koss M
Ophthalmologe; 2015 Feb; 112(2):155-61. PubMed ID: 25305042
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal functional plasminogen in eyes with branch retinal vein occlusion.
Bertelmann T; Sekundo W; Strodthoff S; Witteborn MC; Stief T; Irle S; Nguyen N; Koss MJ; Mennel S
Ophthalmic Res; 2014; 52(2):74-80. PubMed ID: 25059575
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal thrombin activity is elevated in retinal vein occlusion.
Bertelmann T; Stief T; Sekundo W; Mennel S; Nguyen N; Koss MJ
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):654-9. PubMed ID: 24625582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
6. Electroretinograms and level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal vein occlusion or branch retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Ushida H; Piao CH; Kondo M; Terasaki H
Jpn J Ophthalmol; 2014 May; 58(3):232-6. PubMed ID: 24668132
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.
Noma H; Minamoto A; Funatsu H; Tsukamoto H; Nakano K; Yamashita H; Mishima HK
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):309-15. PubMed ID: 16133018
[TBL] [Abstract][Full Text] [Related]
8. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal functional plasminogen is elevated in central retinal vein occlusion.
Bertelmann T; Mennel S; Sekundo W; Strodthoff S; Witteborn MC; Stief T; Nguyen N; Koss MJ
Ophthalmic Res; 2013; 50(3):151-9. PubMed ID: 23948948
[TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in normal vitreous liquid.
Bertelmann T; Stief T; Bölöni R; Schulze S; Wenner Y; Sekundo W; Mennel S
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):217-20. PubMed ID: 24247317
[TBL] [Abstract][Full Text] [Related]
12. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
13. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
14. Effects of apelin and vascular endothelial growth factor on central retinal vein occlusion in monkey eyes intravitreally injected with bevacizumab: a preliminary study.
Zhao T; Lu Q; Tao Y; Liang XY; Wang K; Jiang YR
Mol Vis; 2011 Apr; 17():1044-55. PubMed ID: 21552499
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
16. Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion.
Ehlken C; Rennel ES; Michels D; Grundel B; Pielen A; Junker B; Stahl A; Hansen LL; Feltgen N; Agostini HT; Martin G
Am J Ophthalmol; 2011 Aug; 152(2):298-303.e1. PubMed ID: 21621189
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema.
Noma H; Funatsu H; Mimura T; Harino S; Eguchi S; Hori S
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1559-65. PubMed ID: 20714746
[TBL] [Abstract][Full Text] [Related]
19. High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion.
Tuuminen R; Loukovaara S
Eye (Lond); 2014 Sep; 28(9):1095-9. PubMed ID: 24946846
[TBL] [Abstract][Full Text] [Related]
20. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
